$LUVU
Luvu Brands, Inc.

2022 Q1 Form 10-Q Financial Statement

#000165495422001845 Filed on February 18, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3
Revenue $6.753M $7.186M $6.224M
YoY Change 9.25% 25.76% 15.97%
Cost Of Revenue $4.959M $5.609M $1.000K
YoY Change 11.82% 35.22%
Gross Profit $1.794M $1.577M $1.499M
YoY Change 2.75% 0.7% 0.74%
Gross Profit Margin 26.57% 21.95% 24.08%
Selling, General & Admin $1.182M $1.248M $1.105M
YoY Change 4.69% 17.96% 10.5%
% of Gross Profit 65.89% 79.14% 73.72%
Research & Development $26.59M $32.48M $28.32M
YoY Change 9.72% 19.01% -3.09%
% of Gross Profit 1482.22% 2059.73% 1889.46%
Depreciation & Amortization $74.44K $77.83K $70.69K
YoY Change 38.84% 52.53% 34.77%
% of Gross Profit 4.15% 4.94% 4.72%
Operating Expenses $1.261M $1.326M $1.176M
YoY Change 6.59% 19.57% 11.79%
Operating Profit $533.0K $251.0K $323.0K
YoY Change -5.33% -45.08% -25.92%
Interest Expense -$81.00K -$84.00K -$96.00K
YoY Change -13.83% -4.55% -10.28%
% of Operating Profit -15.2% -33.47% -29.72%
Other Income/Expense, Net -$81.00K -$84.00K -$96.00K
YoY Change -13.83% -108.33% -10.28%
Pretax Income $452.0K $167.0K $227.0K
YoY Change -3.62% -88.6% -31.0%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0% 0.0%
Net Earnings $452.0K $167.0K $227.0K
YoY Change -3.62% -88.6% -31.0%
Net Earnings / Revenue 6.69% 2.32% 3.65%
Basic Earnings Per Share $0.01 $0.00 $0.00
Diluted Earnings Per Share $0.01 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 75.94M shares 75.14M shares 75.04M shares
Diluted Shares Outstanding 76.38M shares 76.61M shares 76.58M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $935.0K $1.081M $961.0K
YoY Change -26.38% 6.5% 3.11%
Cash & Equivalents $935.0K $1.081M $961.0K
Short-Term Investments
Other Short-Term Assets $175.0K $168.0K $159.0K
YoY Change 92.31% 93.1% 76.67%
Inventory $3.807M $3.456M $3.503M
Prepaid Expenses $175.0K $168.0K $159.0K
Receivables $1.351M $920.0K $1.087M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.268M $5.625M $5.710M
YoY Change 15.24% 24.81% 34.45%
LONG-TERM ASSETS
Property, Plant & Equipment $2.083M $1.863M $1.915M
YoY Change -52.55% -53.34% 85.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $100.0K $95.00K
YoY Change 17.65% 316.67% 458.82%
Total Long-Term Assets $4.566M $4.395M $4.517M
YoY Change 2.03% 9.41% 330.19%
TOTAL ASSETS
Total Short-Term Assets $6.268M $5.625M $5.710M
Total Long-Term Assets $4.566M $4.395M $4.517M
Total Assets $10.83M $10.02M $10.23M
YoY Change 9.28% 17.55% 93.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.579M $2.597M $2.725M
YoY Change -2.57% 2.89% 12.51%
Accrued Expenses $617.0K $528.0K $584.0K
YoY Change -21.3% -26.36% -8.75%
Deferred Revenue
YoY Change
Short-Term Debt $1.214M $1.065M $1.114M
YoY Change
Long-Term Debt Due $320.0K $296.0K $312.0K
YoY Change -85.48% -84.04% -87.42%
Total Short-Term Liabilities $5.040M $4.776M $5.005M
YoY Change -10.56% -6.28% -9.69%
LONG-TERM LIABILITIES
Long-Term Debt $1.444M $1.258M $1.327M
YoY Change 91.51% 183.33% 91.21%
Other Long-Term Liabilities $2.164M $2.256M $2.341M
YoY Change -13.61% -7.43%
Total Long-Term Liabilities $3.608M $3.514M $3.668M
YoY Change 10.71% 21.97% 428.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.040M $4.776M $5.005M
Total Long-Term Liabilities $3.608M $3.514M $3.668M
Total Liabilities $8.648M $8.290M $8.673M
YoY Change -2.77% 3.92% 39.08%
SHAREHOLDERS EQUITY
Retained Earnings -$4.747M -$5.199M -$5.366M
YoY Change
Common Stock $759.0K $752.0K $750.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.186M $1.730M $1.554M
YoY Change
Total Liabilities & Shareholders Equity $10.83M $10.02M $10.23M
YoY Change 9.28% 17.55% 93.07%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income $452.0K $167.0K $227.0K
YoY Change -3.62% -88.6% -31.0%
Depreciation, Depletion And Amortization $74.44K $77.83K $70.69K
YoY Change 38.84% 52.53% 34.77%
Cash From Operating Activities -$181.0K $275.0K $169.0K
YoY Change -266.06% 3.38% 30.0%
INVESTING ACTIVITIES
Capital Expenditures -$4.000K $4.000K $61.00K
YoY Change -95.18% -107.41% 117.86%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$4.000K $4.000K -$50.00K
YoY Change -95.18% -107.41% 85.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $200.0K
YoY Change 29.87%
Cash From Financing Activities 39.00K -159.0K -$135.0K
YoY Change -82.97% 23.26% -58.2%
NET CHANGE
Cash From Operating Activities -181.0K 275.0K $169.0K
Cash From Investing Activities -4.000K 4.000K -$50.00K
Cash From Financing Activities 39.00K -159.0K -$135.0K
Net Change In Cash -146.0K 120.0K -$16.00K
YoY Change -157.25% 44.58% -92.73%
FREE CASH FLOW
Cash From Operating Activities -$181.0K $275.0K $169.0K
Capital Expenditures -$4.000K $4.000K $61.00K
Free Cash Flow -$177.0K $271.0K $108.0K
YoY Change -192.19% -15.31% 5.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5700000 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75941860 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1081000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
977000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
920000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1134000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
3456000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
3391000 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
168000 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
145000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
5625000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
5647000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1863000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1934000 USD
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
23000 USD
CY2021Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
27000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2409000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2554000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
100000 USD
CY2021Q2 us-gaap Other Assets
OtherAssets
84000 USD
CY2021Q4 us-gaap Assets
Assets
10020000 USD
CY2021Q2 us-gaap Assets
Assets
10246000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2597000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2669000 USD
CY2021Q4 us-gaap Debt Current
DebtCurrent
1361000 USD
CY2021Q2 us-gaap Debt Current
DebtCurrent
1599000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
528000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
694000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
290000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
250000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4776000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5212000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1258000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1288000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2256000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2423000 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3514000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3711000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
8290000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
8923000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2021Q2 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75260433 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75037890 shares
CY2021Q2 luvu Allowance For Discounts And Returns
AllowanceForDiscountsAndReturns
54000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1134000 USD
CY2021Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1189000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
752000 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
750000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
167000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1465000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
394000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1794000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
167000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1465000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
394000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1794000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2021Q4 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
75139516 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
73682551 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
75088425 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
73567574 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76613472 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74050847 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76594991 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74550249 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-1274000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8000 USD
luvu Stock Option Exercises Amount
StockOptionExercisesAmount
19000 USD
us-gaap Net Income Loss
NetIncomeLoss
1794000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6177000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6166000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5199000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5593000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1730000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1323000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10020000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10246000 USD
CY2021Q4 us-gaap Revenues
Revenues
7186000 USD
CY2020Q4 us-gaap Revenues
Revenues
5714000 USD
us-gaap Revenues
Revenues
13411000 USD
us-gaap Revenues
Revenues
11081000 USD
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5609000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4148000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10335000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8027000 USD
CY2021Q4 us-gaap Gross Profit
GrossProfit
1577000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
1566000 USD
us-gaap Gross Profit
GrossProfit
3076000 USD
us-gaap Gross Profit
GrossProfit
3054000 USD
CY2021Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
155000 USD
CY2020Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
120000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
287000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
189000 USD
CY2021Q4 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
321000 USD
CY2020Q4 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
270000 USD
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
581000 USD
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
537000 USD
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
772000 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
668000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1485000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1332000 USD
CY2021Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
78000 USD
CY2020Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
51000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
149000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
103000 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
1326000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
1109000 USD
us-gaap Operating Expenses
OperatingExpenses
2502000 USD
us-gaap Operating Expenses
OperatingExpenses
2161000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
251000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
457000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
574000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
893000 USD
CY2021Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1096000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1096000 USD
CY2021Q4 us-gaap Financing Interest Expense
FinancingInterestExpense
84000 USD
CY2020Q4 us-gaap Financing Interest Expense
FinancingInterestExpense
88000 USD
us-gaap Financing Interest Expense
FinancingInterestExpense
180000 USD
us-gaap Financing Interest Expense
FinancingInterestExpense
195000 USD
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-84000 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1008000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-180000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
901000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1323000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10000 USD
luvu Stock Option Exercises Amount
StockOptionExercisesAmount
3000 USD
us-gaap Net Income Loss
NetIncomeLoss
394000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-939000 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
2000 USD
CY2020Q4 luvu Stock Option Exercises Amount
StockOptionExercisesAmount
19000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1465000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
547000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1554000 USD
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
6000 USD
CY2021Q4 luvu Stock Option Exercises Amount
StockOptionExercisesAmount
3000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
167000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1730000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
394000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1794000 USD
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 USD
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
1096000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
149000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
103000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1000 USD
us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
144000 USD
us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
164000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
213000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
219000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-65000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-505000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-38000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-39000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-71000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
90000 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-204000 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-190000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
39000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
46000 USD
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-128000 USD
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-199000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
444000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
396000 USD
luvu Investment In Equipment And Leasehold Improvements
InvestmentInEquipmentAndLeaseholdImprovements
-46000 USD
luvu Investment In Equipment And Leasehold Improvements
InvestmentInEquipmentAndLeaseholdImprovements
-81000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-81000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
200000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
239000 USD
us-gaap Proceeds From Unsecured Lines Of Credit
ProceedsFromUnsecuredLinesOfCredit
200000 USD
us-gaap Proceeds From Unsecured Lines Of Credit
ProceedsFromUnsecuredLinesOfCredit
0 USD
luvu Net Cash Provided By Repaid To Line Of Credit
NetCashProvidedByRepaidToLineOfCredit
-49000 USD
luvu Net Cash Provided By Repaid To Line Of Credit
NetCashProvidedByRepaidToLineOfCredit
63000 USD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0 USD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
56000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
117000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
151000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
6000 USD
luvu Accrued Interest Converted For Exercise Of Options
AccruedInterestConvertedForExerciseOfOptions
0 USD
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
4000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
5000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-294000 USD
CY2021Q4 us-gaap Inventory Gross
InventoryGross
3629000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
121000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
69000 USD
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
4000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-452000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
104000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-137000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
977000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1152000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1081000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1015000 USD
us-gaap Notes Issued1
NotesIssued1
28000 USD
us-gaap Notes Issued1
NotesIssued1
357000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
35000 USD
luvu Accrued Interest Converted For Exercise Of Options
AccruedInterestConvertedForExerciseOfOptions
10000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2684000 USD
us-gaap Interest Paid Net
InterestPaidNet
179000 USD
us-gaap Interest Paid Net
InterestPaidNet
193000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">These consolidated financial statements include the accounts and operations of our wholly owned operating subsidiaries, OneUp and Foam Labs. Intercompany accounts and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current year presentation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">The accompanying consolidated condensed financial statements have been prepared in accordance with GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. These consolidated condensed financial statements and notes should be read in conjunction with the Company’s consolidated financial statements contained in the Company’s 2021 10-K.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 35.45pt; text-align:left;"> The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Significant estimates in these consolidated financial statements include estimates of: income taxes; tax valuation reserves; allowances for doubtful accounts; inventory valuation and reserves; share-based compensation; and useful lives for depreciation and amortization. Actual results could differ materially from these estimates. </p>
CY2021Q2 us-gaap Inventory Gross
InventoryGross
3564000 USD
CY2021Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
16965000 USD
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
17665000 USD
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
956000 USD
CY2021Q2 luvu Allowance For Doubtful Accounts Receivables
AllowanceForDoubtfulAccountsReceivables
1000 USD
CY2021Q4 luvu Allowance For Doubtful Accounts Receivables
AllowanceForDoubtfulAccountsReceivables
1000 USD
CY2021Q4 luvu Allowance For Discounts And Returns
AllowanceForDiscountsAndReturns
35000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
920000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">The Company maintains its cash accounts with banks located in Georgia. The total cash balances are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 per bank. The Company had bank balances on deposit at December 31, 2021 that exceeded the balance insured by the FDIC by $1,134,840. Accounts receivable are typically unsecured and are derived from revenue earned from customers primarily located in North America and Europe.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">During the three and six months ended December 31, 2021, we purchased 35% and 36% respectively, of total inventory purchases from one vendor.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">During the fiscal year ended June 30, 2021, we purchased 34% of total inventory purchases from one vendor.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">As of December 31, 2021, two of the Company’s customers represents 30% and 19% of the total accounts receivables, respectively. As of June 30, 2021, two of the Company’s customers represents 40% and 14% of the total accounts receivables, respectively. For the three and six months ended December 31, 2021, sales to and through Amazon accounted for 32% and 31% of our net sales, respectively.</p>
CY2021Q4 us-gaap Cash
Cash
250000 USD
CY2021Q4 luvu Fdic Balance Limit Excess
FdicBalanceLimitExcess
1134840000 USD
CY2021Q4 luvu Inventory Valuation Reserve
InventoryValuationReserve
-173000 USD
CY2021Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
1050000 USD
CY2021Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
5000000 USD
CY2021Q4 us-gaap Advertising Expense
AdvertisingExpense
154876000 USD
CY2020Q4 us-gaap Advertising Expense
AdvertisingExpense
120455000 USD
us-gaap Advertising Expense
AdvertisingExpense
286766000 USD
us-gaap Advertising Expense
AdvertisingExpense
188985000 USD
CY2021Q4 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
32482000 USD
CY2020Q4 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
27294000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
60805000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
56519000 USD
luvu Impairment Or Disposal Of Long Lived Assetspolicy
ImpairmentOrDisposalOfLongLivedAssetspolicy
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">Long-lived assets to be held are reviewed for events or changes in circumstances which indicate that their carrying value may not be recoverable. They are tested for recoverability using undiscounted cash flows to determine whether or not impairment to such value has occurred as required by Financial Accounting Standards Board (“<em>FASB”) ASC Topic No. 360, Property, Plant, and Equipment</em>. The Company has determined that there was no impairment at December 31, 2021.</p>
CY2021Q2 luvu Inventory Valuation Reserve
InventoryValuationReserve
-173000 USD
CY2020Q4 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
88120000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
176239000 USD
CY2021Q4 luvu Rental Abatement
RentalAbatement
103230000 USD
CY2021Q4 us-gaap Capital Leases Contingent Rental Payments Due
CapitalLeasesContingentRentalPaymentsDue
51615000 USD
luvu Final Two Months Rent
FinalTwoMonthsRent
61605 USD
CY2021Q4 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
163188000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
326376000 USD
us-gaap Revenues
Revenues
13411000 USD
us-gaap Revenues
Revenues
11081000 USD
luvu Percent Change In Sales
PercentChangeInSales
0.21 pure
CY2021Q4 us-gaap Revenues
Revenues
7186000 USD
CY2020Q4 us-gaap Revenues
Revenues
5714000 USD
CY2020Q4 luvu Percent Change In Sales
PercentChangeInSales
0.26 pure
CY2021Q4 us-gaap Gross Profit
GrossProfit
1577000 USD
CY2021Q4 luvu Gross Profit Margin
GrossProfitMargin
0.22 pure
CY2020Q4 us-gaap Gross Profit
GrossProfit
1566000 USD
CY2020Q4 luvu Gross Profit Margin
GrossProfitMargin
0.27 pure
CY2021Q4 luvu Percent Change
PercentChange
0.01 pure
us-gaap Gross Profit
GrossProfit
3076000 USD
us-gaap Gross Profit
GrossProfit
3054000 USD
luvu Gross Profit Margin
GrossProfitMargin
0.28 pure
luvu Percent Change
PercentChange
0.01 pure
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5698000 USD
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
425000 USD
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
396000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1371000 USD
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1531000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6450000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6600000 shares
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1833000 USD
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1637000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
3456000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
3391000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5620000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3835000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3686000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1863000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1934000 USD
CY2021Q4 us-gaap Depreciation
Depreciation
77825 USD
CY2020Q4 us-gaap Depreciation
Depreciation
51024 USD
us-gaap Depreciation
Depreciation
148513 USD
us-gaap Depreciation
Depreciation
103476 USD
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
304000 USD
CY2021Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
509000 USD
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
224000 USD
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
185000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
528000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
694000 USD
CY2021Q4 us-gaap Unsecured Debt
UnsecuredDebt
31 USD
CY2021Q2 us-gaap Unsecured Debt
UnsecuredDebt
37 USD
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1034000 USD
CY2021Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1083000 USD
CY2021Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
0 USD
CY2021Q2 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
100000 USD
CY2021Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
219000 USD
CY2021Q4 us-gaap Mediumterm Notes Current
MediumtermNotesCurrent
35000 USD
CY2021Q2 us-gaap Mediumterm Notes Current
MediumtermNotesCurrent
152000 USD
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
9000 USD
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
8000 USD
CY2021Q4 us-gaap Debt Current
DebtCurrent
1361000 USD
CY2021Q2 us-gaap Debt Current
DebtCurrent
1599000 USD
CY2021Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
400000 USD
CY2021Q2 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
300000 USD
CY2021Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
14000 USD
CY2021Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
19000 USD
CY2021Q4 us-gaap Other Notes Payable
OtherNotesPayable
728000 USD
CY2021Q2 us-gaap Other Notes Payable
OtherNotesPayable
853000 USD
CY2021Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
116000 USD
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
116000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1258000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1288000 USD
CY2021Q2 us-gaap Notes Payable Current
NotesPayableCurrent
100 USD
CY2021Q2 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
100000 USD
CY2021Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
400000 USD
CY2021Q2 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
300000 USD
CY2021Q2 us-gaap Notes Payable
NotesPayable
400000 USD
CY2021Q4 us-gaap Notes Payable
NotesPayable
400000 USD
CY2021Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
116000 USD
CY2021Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
116000 USD
CY2021Q4 luvu Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
0 USD
CY2021Q2 luvu Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
0 USD
CY2021Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
116000 USD
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
116000 USD
CY2021Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
750000 USD
us-gaap Line Of Credit Facility Collateral
LineOfCreditFacilityCollateral
85% of eligible accounts receivable (as defined in the agreement) for the purpose of improving working capital.
us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
2.5% over the lenders Index Rate.
CY2021Q4 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.025 pure
us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
0.0125 pure
CY2021Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.02 pure
CY2021Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.08 pure
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
30882 USD
CY2021Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
36680 USD
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
1096200000 USD
CY2021Q4 us-gaap Federal Home Loan Bank Advances Interest Rate
FederalHomeLoanBankAdvancesInterestRate
0.010 pure
us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
61691000 USD
luvu Gain On Forgiveness Of Sba Loan
GainOnForgivenessOfSbaLoan
1096200 USD
luvu Weighted Average Remaining Lease Term
WeightedAverageRemainingLeaseTerm
P6Y
luvu Weighted Average Discount Rate
WeightedAverageDiscountRate
0.1449 pure
CY2021Q4 luvu Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
2409000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
290000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2256000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2546000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
312000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
642000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
680000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
721000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1290000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling After Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive
3645000 USD
CY2021Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
-1099 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2546000 USD
CY2021Q4 luvu Equipment Notes Payable
EquipmentNotesPayable
1463893 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.05
CY2021Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
311000 USD
CY2021Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
163000 USD
CY2021Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
290000 USD
CY2021Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
245000 USD
CY2021Q4 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
127000 USD
CY2021Q4 luvu Future Minimum Lease Payments
FutureMinimumLeasePayments
1136000 USD
CY2021Q4 luvu Amount Representing Interest
AmountRepresentingInterest
-156 USD
CY2021Q4 us-gaap Contractual Obligation
ContractualObligation
980000 USD
CY2021Q4 luvu Other Note Payable Current
OtherNotePayableCurrent
252000 USD
CY2021Q4 us-gaap Other Notes Payable
OtherNotesPayable
728000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
3150000 shares
CY2021Q4 luvu Number Of Shares Available For Issuance Under Plan
NumberOfSharesAvailableForIssuanceUnderPlan
1000000 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2500000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y10M24D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.04
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
974300 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
50000 shares
luvu Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted
P4Y7M6D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.30
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
250000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.04
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
150000 shares
luvu Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3
P3Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.03
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2150000 shares
luvu Weighted Average Remaining Contractual Life Ending
WeightedAverageRemainingContractualLifeEnding
P1Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
150000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.30
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
565200 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1625000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y9M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.03
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
456300 USD
CY2021Q4 us-gaap Share Price
SharePrice
0.31
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
250000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1600000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
50000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
5 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0065 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0025 pure
luvu Share Based Compensation Arrangements By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardVestingPeriod1
4 years
luvu Share Based Compensation Arrangements By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardVestingPeriod1
4 years
luvu Forfeiture Rate
ForfeitureRate
0 pure
luvu Forfeiture Rate
ForfeitureRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P4Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P4Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2150000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y4M24D
CY2021Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.05
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1625000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.03
luvu Sharebased Compensation Not Yet Recognized
SharebasedCompensationNotYetRecognized
44158 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8000 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
3150000 shares
CY2021Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
4300000 shares
CY2022Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
681427 USD
CY2022Q1 luvu Stock Options Were Exercised For Cash
StockOptionsWereExercisedForCash
800000 shares
CY2022Q1 us-gaap Investment Maturity Date
InvestmentMaturityDate
2022-02-12
CY2022Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
297500 USD
CY2022Q1 us-gaap Other Investments
OtherInvestments
60 USD
CY2022Q1 us-gaap Investments
Investments
5915 USD

Files In Submission

Name View Source Status
0001654954-22-001845-index-headers.html Edgar Link pending
0001654954-22-001845-index.html Edgar Link pending
0001654954-22-001845.txt Edgar Link pending
0001654954-22-001845-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
luvu-20211231.xsd Edgar Link pending
luvu-20211231_cal.xml Edgar Link unprocessable
luvu-20211231_def.xml Edgar Link unprocessable
luvu-20211231_lab.xml Edgar Link unprocessable
luvu-20211231_pre.xml Edgar Link unprocessable
luvu_10q.htm Edgar Link pending
luvu_10q_htm.xml Edgar Link completed
luvu_ex311.htm Edgar Link pending
luvu_ex312.htm Edgar Link pending
luvu_ex321.htm Edgar Link pending
luvu_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending